Lefkowitz Steven W 4

What Happened

• Steven W. Lefkowitz, a director of CorMedix, received an award of 30,453 restricted stock units (RSUs) on January 26, 2026. The grant was reported at $0.00 per unit (no cash paid at grant). The RSUs represent the right to one share of CorMedix common stock each and will vest in full on January 26, 2027, subject to continued service.

Key Details

• Transaction date and type: 2026-01-26 — Award/Grant (RSUs) at $0.00 per unit.
• Quantity granted: 30,453 restricted stock units.
• Vesting: RSUs vest in full on 2027-01-26, subject to continued service (Footnote F1).
• Shares owned after transaction: total post-transaction holdings not specified in the filing; filing notes beneficial ownership through Wade Capital Corporation Money Purchase Plan (Footnote F2).
• Filing timeliness: Report period 2026-01-26, filed 2026-01-27 — appears timely (not marked late).

Context

• RSU grants are a form of compensation and do not involve an open-market purchase or sale; they convert into shares only upon vesting, so this is not an immediate buy/sell signal. Footnote F2 indicates some beneficial ownership is held via a retirement/plan vehicle over which the reporting person has voting and investment control.